465 related articles for article (PubMed ID: 18683748)
21. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
22. [The UCSNP44 variation of calpain 10 gene on NIDDM1 locus and its impact on plasma glucose levels in type 2 diabetic patients].
Wang Y; Xiang K; Zheng T; Jia W; Shen K; Li J
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):613-6. PubMed ID: 12133483
[TBL] [Abstract][Full Text] [Related]
23. [Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].
Li C; Zhan Y; Li GZ; Liu SG
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):342-6. PubMed ID: 22883521
[TBL] [Abstract][Full Text] [Related]
24. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
25. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.
Panidis D; Kourtis A; Kukuvitis A; Farmakiotis D; Xita N; Georgiou I; Tsatsoulis A
Hum Reprod; 2004 Aug; 19(8):1728-33. PubMed ID: 15178661
[TBL] [Abstract][Full Text] [Related]
26. [Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].
Wang Y; Hu ZP; Li MZ; Li R; Wang LN; Chen XN; Yang CS; Qiao J
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2599-603. PubMed ID: 20137674
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
[TBL] [Abstract][Full Text] [Related]
28. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome.
Wang K; Wang L; Zhao Y; Shi Y; Wang L; Chen ZJ
Hum Reprod; 2009 Feb; 24(2):485-90. PubMed ID: 19049992
[TBL] [Abstract][Full Text] [Related]
29. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
30. [Association of the calpain-10 gene polymorphism with glucose metabolism disorder in pregnant women].
Wu HR; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):183-7. PubMed ID: 19570442
[TBL] [Abstract][Full Text] [Related]
31. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Yilmaz C
Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034
[TBL] [Abstract][Full Text] [Related]
32. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
33. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
34. Association of Calpain (CAPN) 10 (UCSNP-43, rs3792267) gene polymorphism with elevated serum androgens in young women with the most severe phenotype of polycystic ovary syndrome (PCOS).
Anastasia K; Koika V; Roupas ND; Armeni A; Marioli D; Panidis D; George A; Georgopoulos NA
Gynecol Endocrinol; 2015; 31(8):630-4. PubMed ID: 26376770
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
36. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
[TBL] [Abstract][Full Text] [Related]
37. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
[TBL] [Abstract][Full Text] [Related]
38. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
39. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.
Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM
Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383
[TBL] [Abstract][Full Text] [Related]
40. [Association of SNP276 in adiponectin gene with type 2 diabetes mellitus and insulin sensitivity].
Ru Y; Ma M; Ma T; Wang CJ; Wang YM; Zhang Q; Chen MW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):698-701. PubMed ID: 16331577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]